About this trial
This study aims to investigate the effects of different types of respiratory muscle training on lung function, diaphragm movement, and voice quality in patients with Parkinson's disease (PD). PD often leads to breathing difficulties and voice abnormalities due to weakened respiratory muscles and reduced diaphragm mobility. The study will involve 45 participants with PD, randomly assigned to three groups: one group will perform inspiratory muscle training, the second group will perform both inspiratory and expiratory muscle training, and the third group will receive placebo-controlled expiratory muscle training. The hypothesis is that targeted respiratory muscle training will significantly improve pulmonary function, diaphragm excursion, and phonatory measures compared to the placebo group. The findings aim to develop effective rehabilitation strategies to enhance the quality of life and communication abilities in individuals with PD.
Eligibility criteria
Qualifiers
Patients with Parkinson's disease (Hoehn & Yahr stage I-III),
Patients aged 30-85
Patients with stable medical condition, regular medication adherence, and ability to follow instructions.
Disqualifiers
Patients with cognitive impairment
Patients with respiratory or other neurological diseases
Patients with smoking history
Patients with respiratory complications
Trial design
Treatments tested in this trial
- respiratory muscle training
- Expiratory Muscle Training
- Placebo-Controlled Expiratory Muscle Training